epatitis C virus (HCV) has been associated with cryoglobulinemia, Sjögren's syndrome, membranoproliferative glomerulonephritis, sporadic porphyria cutanea tarda, leukocytoclastic vasculitis, and idiopathic pulmonary fibrosis. 1 We found an association of HCV infection with dilated cardiomyopathy, 2,3 and a more recent report supports our findings. 4 Hypertrophic cardiomyopathy (HCM) is characterized by inappropriate myocardial hypertrophy and a variety of clinical manifestations, including sudden death, which can strike both symptomatic and asymptomatic individuals. Pathologic findings consist of increased myocardial mass and myofiber disarray. Familial HCM has been found to be caused by mutations in the genes for -cardiac myosin heavy chain, 5 -tropomyosin, and cardiac troponin T. 6 However, in over 50% of familial cases, and in most cases of non-familial HCM, the cause remains unknown. The etiology of HCM may be heterogeneous; for instance, a recent study reported that Fabry's disease was also associated with left ventricular hypertrophy. 7 Myocarditis has been reported to lead to asymmetrical septal hypertrophy, which is one of the characteristic clinical features of HCM. [8] [9] [10] We have shown, in a preliminary study, that the anti-HCVantibody was more prevalent in patients with HCM than in those with ischemic heart disease 11 or dilated cardiomyopathy. 12 The present study shows an association of HCV infec-tion with HCM, particularly of the apical variety, and describes the clinical features, histopathologic findings, and HCV genome analysis in patients with HCM.
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The familial form of hypertrophic cardiomyopathy (HCM) is attributed to mutations in the genes for contractile proteins, but the etiology of non-familial form remains unknown. This study was designed to examine the clinical features, histopathologic changes, and hepatitis C virus (HCV) genomes in patients with HCM associated with HCV infection. Anti-HCV antibody was present in the sera of 9 of 65 patients (13.8%) with HCM versus 2.41% in a control population of voluntary blood donors in Japan, a statistically significant difference (p<0.0001). Among these 9 patients, 6 had ace-of-spades-shaped deformities of the left ventricle with apical hypertrophy. Myocardial fibrosis was found in all patients, and mild cellular infiltration was observed in 5 patients. Type 1b HCV RNA was present in the sera of 5 of the 9 patients. The copy number of HCV was 5.5×10 3 -8.6×10 5 genomes/ml serum, and multiple clones of HCV were detected in the sera of each patient by an analysis of the hypervariable regions using fluorescent single-strand conformation polymorphism. Positive strands of HCV were found in the hearts of 5 patients, and negative strands in the hearts of 2 patients. A high prevalence of HCV infection was found in patients with HCM, particularly of the apical variety, suggesting that HCV is an important causal agent in the pathogenesis of the disease. (Jpn Circ J 1999; 63: 433 -438) Japanese Circulation Journal Vol.63, June 1999 nitrogen for molecular studies. Multiple sections of the biopsy were stained with hematoxylin and eosin and examined by light microscopy. The samples from one patient were obtained at the time of autopsy. Blood was collected at the time of diagnostic catheterization, and the separated serum was stored at -80°C until the time of assay. The prevalence of antibodies against HCV was compared with that of voluntary blood donors in Japan. Antibodies against HCV were detected by a secondgeneration immunoradiometric assay (Ortho Diagnostics, Ranton, NJ, USA). Hepatitis C virus RNA was detected by nested polymerase chain reaction, as described previously. 2 The histopathological changes of myocyte hypertrophy, fibrosis and cellular infiltration were graded as mild, moderate or severe. Hepatitis C virus types were determined on the basis of variations in nucleotide sequence within restricted regions in the putative C (core) gene of the hepatitis C virus. 13 The method used to quantify HCV RNA in serum was a competitive assay based on coamplification of the target RNA with known amounts of synthetic mutated RNA. 14 In the blood of a given patient infected with the hepatitis C virus, a population of closely related mutants, known as quasispecies, is observed. Fluorescent single-strand conformation polymorphism (f-SSCP) was used for the analysis of quasispecices of the hypervariable region I (HVRI) of the HCV genome. 15 
Statistical Analysis
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Results
Over a 7-year period, 9 of 65 patients (13.8%) with HCM were identified who had evidence of HCV infection on the basis of positive HCV antibody. In contrast, the prevalence of positive HCV antibody in voluntary blood donors in Japan was 2.41% in subjects 55-59 years of age (n=1,039, data from the Japan Red Cross Blood Center, November, 1990). The difference was statistically significant ( 2 =26.8, p<0.0001).
Of these 9 patients, 3 were men and 6 were women; their average age was 61.2 years (range, 50-71 years). Four patients had a history of mild hypertension. None of the patients had a family history of HCM. Symptoms consisted of chest pain in 2 patients, exertional shortness of breath in 2 patients, and palpitation in 2 patients (Table 1) . Two patients had histories of chronic hepatitis, but the others had no known risk factors for HCV infection, such as a history of intravenous drug use or previous blood transfu-sions (Table 1) . Mildly elevated serum aminotransferases was detected in 6 patients.
Two patients had tall R waves in lead V5 of the surface electrocardiogram, and 2 patients showed giant negative T waves in leads V4 or V5 (Fig 1, Table 2 ). The 2-dimensional and M-mode echocardiogram showed mild to moderate thickening of the interventricular septum and of the left ventricular posterior wall. Three patients showed asymmetric septal hypertrophy (Fig 2) . The left ventricular end-diastolic pressure was increased in 5 patients. A pressure gradient within the left ventricle was not detected in any of the patients (Table 3 ). Six patients had ace-of-spades-shaped deformities of the left ventricle with a ratio of apical thickness to middle anterior free wall thickness > 1.3 ( Table 3 , Fig 3) . None had angiographically visible coronary artery disease.
Histopathological studies showed mild to severe degrees of myocyte hypertrophy in the right or left ventricle, and mild to moderate fibrosis. Mild cellular infiltration was seen in 5 patients (Fig 4, Table 4 ). Type 1b HCV RNA was detected in the serum of 5 patients (Table 5 ). Quantitative analysis of HCV RNA by competitive nested polymerase chain reaction showed that the copy number in the serum was 5.5×10 3 -8.6×10 6 genomes/ml. Hepatitis C virus RNA was found in the biopsy specimens of patients 1, 2, 6, 7 and 9 ( Fig 5) . Biopsy specimens were analyzed for HCV genomes in 3 of the 6 patients with apical hypertrophy, and were found positive for HCV RNA in all 3. Analysis by f-SSCP showed the presence of multiple clones in the sera of 5 patients with HCM ( Fig 6, Table 5 ). Negative strands of HCV RNA were found in the hearts of patients 6 and 9 (Fig 5) .
Discussion
In this study, a high prevalence of HCV infection was found in patients with HCM, and HCV RNA was detected in the hearts of 5 patients, despite being undetectable in the sera of 1 of them, which suggests that the HCV may replicate in the heart and may contribute to cardiac hypertrophy. Because negative RNA molecules are considered to be intermediaries in the replication of the HCV genome, the detection of negative strands of HCV in 2 endomyocardial specimens suggests that the HCV does replicate in the heart. 16 Of the 9 HCV-infected patients with HCM, 6 had hypertrophy of the apical region of the left ventricle. Apical hypertrophy was originally described by Sakamoto et al 17 and Yamaguchi et al 18 as a morphologic variant of the disease in which hypertrophy is present predominantly in the apical region of the left ventricle. This variant of HCM is characterized by giant T wave inversion and an angiographic 'ace-of-spades'-shaped appearance of the left ventricle. In subsequent studies from centers outside Japan, [19] [20] [21] [22] [23] [24] most of the non-Japanese patients with the apical form of HCM did not have the characteristic giant negative T waves. The reason for the different phenotypic expression of apical hypertrophy in different parts of the world is unknown, but it is most likely related to differences in patient selection. 25 More recently, giant negative T waves have been shown to resolve during long-term follow-up. 26 Typically, apical HCM has been observed in older males, often in association with systemic hypertension, without apparent genetic transmission. 27 In the present study, 4 of the 6 patients with apical hypertrophy were female, and a history of mild hypertension was present in only 2. The histopathological findings of myocyte hypertrophy and fibrosis in most patients, and mild cellular infiltration with myocardial fibrosis in 5, suggested the presence of chronic myocarditis.
The HCV is a single-stranded RNA virus that frequently causes chronic liver disease. 28 Since the cloning and expression of its genome, 27,29 many different HCV-sequences have been reported from all over the world. These genomes are classified into 6 genotypes, 30 which show variable degrees of homology in different regions of the genome. 31 The highest homology is found in the 5'-non-coding region, whereas the nucleotide sequence of the N-terminus of the putative envelope protein, the so-called hypervariable region I, is extremely variable. [32] [33] [34] In the blood of a given patient infected with the HCV, a population of closely related mutants, termed quasispecies, is observed. Fluorescent single-stranded conformation polymorphism analysis is a new method to detect point mutation in nucleic acids, 35, 36 useful for the detection of the heterogeneity of a viral population in patients with HCV infection without having to sequence a large number of HCV clones. Host factors such as age, gender, major histocompatibility complex and immunocompetence, as well as viral factors such as virus titer and genotype, have been shown to be important factors influencing the clinical outcome. [37] [38] [39] [40] [41] [42] In addition, the heterogeneity and complexity of the patient's virus population may be a predictor of therapeutic response to interferon. [43] [44] [45] In the present study, multiple clones were identified in the sera of the patients, which suggests that specific clones with high affinity for the heart cause HCM. The most remarkable feature of hepatitis C is the risk of persistent infection and progression to chronic liver disease. Persistent infection occurs in more than 50% of patients with HCV infection and may lead to chronic active hepatitis, cirrhosis and hepatocellular carcinoma. 46 As adults myocytes may not replicate, and the growth stimuli provided by HCV infection may cause HCM.
Hypertrophic cardiomyopathy is a family of diseases, with genetic and non-genetic etiologies, which occur throughout the world. It is characterized by morphologically diverse patterns of left ventricular hypertrophy ranging from marked diffuse thickening of the ventricular septum and left ventricular free wall to focal hypertrophy of the apical region. The reason why the apical part of the left ventricule develops hypertrophy is unknown. Viral myocarditis presents in various forms. When myocardial lesions are localized, ventricular aneurysms occur in animals with picornavirus infection such as coxsackievirus or encephalomyocarditis virus. 3, [47] [48] [49] [50] As HCV may initiate hypertrophy of myocytes, it is possible that apical hypertrophy may develop when HCV localizes at the apical part of the left ventricle. The other possibility is that hypertrophy of the ventricle may be different depending on host factors, such as the major histocompatibility complex, because it has been shown that the major histocompatibility complex influences the clinical manifestations and outcome of HCV hepatitis. 51, 52 Further studies are necessary to clarify the mechanism of localization of hypertrophy caused by HCV infection. However, the present study suggests that HCV infection is an important cause of the apical and other forms of the disease.
